<div class="qMYqUG_convSearchResultHighlightRoot">
<div class="" data-turn-id-container="request-WEB:358025a4-babd-4cd5-8368-0989249581f5-4" data-is-intersecting="true">
<section class="text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-WEB:358025a4-babd-4cd5-8368-0989249581f5-4" data-turn-id-container="request-WEB:358025a4-babd-4cd5-8368-0989249581f5-4" data-testid="conversation-turn-10" data-turn="assistant">
<div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)">
<div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn" data-conversation-screenshot-content="">
<div class="flex max-w-full flex-col gap-4 grow">
<div class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1" dir="auto" tabindex="0" data-message-author-role="assistant" data-message-id="b889d53a-36fb-4739-ae44-5127c67b0f7b" data-message-model-slug="gpt-5-5" data-turn-start-message="true">
<div class="flex w-full flex-col gap-1 empty:hidden">
<div class="markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling">
<p class="PDq2pG_selectionAnchorContainer" data-start="0" data-end="125">Model: 4-week-old <span class="hover:entity-accent entity-underline inline cursor-pointer align-baseline"><span class="whitespace-normal">SM/J</span></span> mice (with <span class="hover:entity-accent entity-underline inline cursor-pointer align-baseline"><span class="whitespace-normal">C57BL/6J</span></span> comparison mice)</p>
<p data-start="127" data-end="279" data-is-last-node="" data-is-only-node="">Dosage: Weekly intraperitoneal injections of 40 mg/kg Navitoclax or 5 mg/kg Dasatinib + 50 mg/kg Quercetin from 4 to 6–8 or 17 weeks of age.</p>
</div>
</div>
</div>
</div>
<div class="z-0 flex min-h-[46px] justify-start"></div>
<div class="mt-3 w-full empty:hidden">
<div class="text-center"></div>
</div>
</div>
</div>
</section>
</div>
</div>
<div class="pointer-events-none -mt-px h-px translate-y-[calc(var(--scroll-root-safe-area-inset-bottom)-14*var(--spacing))]" aria-hidden="true"></div>


Dasatinib and Quercetin Delay Early-Onset Disc Degeneration in Mice

Researchers find that clearing senescent cells preserves disc structure and slows early-onset disc degeneration in mice.


Aging &amp; Longevity

<p>Model: 10-month-old and 22-month-old naturally aged mice / Rats with Partial Discectomy (PDE)-induced Temporomandibular Joint Osteoarthritis (TMJOA).</p>
<p>Dosage: <span style="font-weight: 400;">0.25% αKG and  0.75% αKG</span></p>
<p>&nbsp;</p>


Longevity Compound Thwarts Age-Related Joint Degeneration: New Study Reveals

Researchers found that alpha-ketoglutarate (αKG) can treat osteoarthritis by preserving cartilage and reducing joint inflammation. 

Skin &amp; Muscle

 Peptide therapies, stem cell treatments, and NAD+ supplementation are being studied for their potential to thwart age-related decline. 

Bryan Johnson Injects 300 Million Stem Cells in Latest Longevity Ploy

Bryan Johnson traveled to Cell Colabs in the Bahamas to inject his major joints with 300 million stem cells for enhanced performance and longevity. 

The Cleveland Clinic’s Dr. Michael Roizen Says Age 90 May Become the New 40

Dr. Michael Roizen, the Chief Wellness Officer at the Cleveland Clinic, believes there is an 80% probability of aging interventions making 90-year-olds 40 again within the next decade.

(Dr. Michael Roizen, the Cleveland Clinic’s Chief Wellness Officer | YouTube)

The Cleveland Clinic’s Chief Wellness Officer, Dr. Michael Roizen, believes there is an 80% probability of making 90-year-olds 40 again via new longevity interventions developed in the next decade.

Search Result: Cartilage

Dasatinib and Quercetin Delay Early-Onset Disc Degeneration in Mice

Longevity Compound Thwarts Age-Related Joint Degeneration: New Study Reveals

Can We Slow Down Aging? Inside the Cutting-Edge Science of Peptides, Stem Cells, and NAD+

Bryan Johnson Injects 300 Million Stem Cells in Latest Longevity Ploy

The Cleveland Clinic’s Dr. Michael Roizen Says Age 90 May Become the New 40